| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.025 |
0.9 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.0012 |
1 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
| mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.001 |
1 |
| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.00089 |
1 |